Tiderström G, Heinegård D
Clin Chim Acta. 1978 Sep 1;88(2):293-304. doi: 10.1016/0009-8981(78)90434-5.
The "oxytocinase" activity has been determined as the CAP (cystyl-aminopeptidase, EC 3.4.11.3) activity with several substrates. It was demonstrated that serum samples from pregnant women and patients with serious liver disease had increased CAP activities compared with normal serum. It was also shown that seminal plasma had very high CAP activity. The pH optimum for the enzymes from the various sources differed, as did the metal dependence. Furthermore, samples from patients with liver disease had higher CAP activities when assayed in buffers containing amino groups, in contrast to the other samples. Gel chromatography and gel electrophoresis revealed the presence of several isoenzymes. The serum from pregnant women contained an isoenzyme neither present in normal plasma nor in any of the other sources tested. It is possible that this isoenzymes represents the true oxytocinase. CAP and LAP (leucine aminopeptidase) activities were very well correlated in serum from pregnant women and seminal plasma, while the correlation for samples from patients with liver disease was not as good. When care was taken to determine the CAP activity at the right pH and with the appropriate buffer, the risk for interference from other enzymes was minimized in the determination of oxytocinase as CAP activity.
已通过几种底物将“催产素酶”活性测定为胱氨酰氨肽酶(CAP,EC 3.4.11.3)活性。结果表明,与正常血清相比,孕妇和重症肝病患者的血清样本中CAP活性升高。还表明精浆具有非常高的CAP活性。来自不同来源的酶的最适pH不同,对金属的依赖性也不同。此外,与其他样本相比,在含有氨基的缓冲液中测定时,肝病患者的样本具有更高的CAP活性。凝胶色谱法和凝胶电泳显示存在几种同工酶。孕妇血清中含有一种在正常血浆和任何其他测试来源中均不存在的同工酶。这种同工酶有可能代表真正的催产素酶。孕妇血清和精浆中CAP和亮氨酸氨肽酶(LAP)活性相关性非常好,而肝病患者样本的相关性则没那么好。当注意在合适的pH下并使用适当的缓冲液来测定CAP活性时,在将催产素酶活性测定为CAP活性的过程中,其他酶干扰的风险会降至最低。